Universe Pharmaceuticals (UPC) Long-Term Investments (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Long-Term Investments of $724848.0 for Q1 2026, up 3.2% sequentially from $702346.0 in Q3 2025.
Universe Pharmaceuticals (UPC) Long-Term Investments (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Long-Term Investments for 7 years, with the latest figure at $724848.0 in Q1 2026.
- Quarterly Long-Term Investments changed N/A year-over-year to $724848.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $724848.0 (changed N/A YoY) and the FY2025 annual result came in at $702346.0, down 99.9% from the prior year.
- Long-Term Investments climbed to $724848.0 in Q1 2026 per UPC's latest filing, from $702346.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $712.5 million in Q3 2024 and troughed at $586674.0 in Q1 2022.
- A 5-year average of $177.4 million and a median of $713869.0 in 2022 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2023 and 2025: Long-Term Investments soared 99822.61% in 2023, then plunged 99.9% in 2025.
- Over 5 years, Long-Term Investments stood at $702890.0 in 2022, then jumped by 99822.61% to $702.3 million in 2023, then gained by 1.44% to $712.5 million in 2024, then slumped by 99.9% to $702346.0 in 2025, then grew by 3.2% to $724848.0 in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $724848.0, $702346.0, and $712.5 million for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | Universe Pharmaceuticals | 2.93 Mn | -26.11 Mn | - | 724,848.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,848.00 |
| Sep 30, 2025 | 702,346.00 |
| Sep 30, 2024 | 712.49 Mn |
| Mar 31, 2024 | 692,492.00 |
| Sep 30, 2023 | 702.35 Mn |
| Mar 31, 2023 | 728,055.00 |
| Sep 30, 2022 | 702,890.00 |
| Mar 31, 2022 | 586,674.00 |
| Sep 30, 2021 | 744,924.00 |
| Sep 30, 2020 | 735.00 Bn |